Reltecimod TFA

TargetMol Chemicals

Reltecimod TFA

14

Research Use Only

Reltecimod TFA

C46H72N10O15S.xC2HF3O2

1037.19 (free base)

Reltecimod (AB-103) TFA is an antagonist of the T-cell-specific surface glycoprotein CD28 (TP44), demonstrating efficacy against various bacterial infections, including exotoxins, endotoxins, and ionizing radiation. By modulating the inflammatory response through attenuation of the key CD28/B7-2 co-stimulatory pathway without full inhibition, Reltecimod TFA is utilized in researching necrotizing soft-tissue infections (NSTIs) [1].

3 years

-20°C

12352200